L-659,699
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532062

CAS#: 29066-42-0

Description: L-659,699, also known as hymeglusin, is a fungal β-lactone antibiotic that inhibits HMG-CoA synthase (IC50 = 0.12 μM) by covalently modifying the active Cys129 residue of the enzyme.


Chemical Structure

img
L-659,699
CAS# 29066-42-0

Theoretical Analysis

MedKoo Cat#: 532062
Name: L-659,699
CAS#: 29066-42-0
Chemical Formula: C18H28O5
Exact Mass: 324.19
Molecular Weight: 324.417
Elemental Analysis: C, 66.64; H, 8.70; O, 24.66

Price and Availability

Size Price Availability Quantity
1mg USD 415 2 Weeks
Bulk inquiry

Synonym: Hymeglusin; L-659,699; L 659,699; L659,699.

IUPAC/Chemical Name: (2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

InChi Key: ODCZJZWSXPVLAW-KXCGKLMDSA-N

InChi Code: InChI=1S/C18H28O5/c1-12(8-13(2)9-14(3)10-17(20)21)6-4-5-7-16-15(11-19)18(22)23-16/h9-10,12,15-16,19H,4-8,11H2,1-3H3,(H,20,21)/b13-9+,14-10+/t12-,15-,16-/m1/s1

SMILES Code: O=C(O)/C=C(C)/C=C(C)/C[C@H](C)CCCC[C@H]([C@H]1CO)OC1=O

Appearance: Solid powder

Purity: >95% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: Hymeglusin, as a fungal β-lactone Antibiotic, is a HMG-CoA synthase inhibitor (IC50 = 0.12 μM).
In vitro activity: Hymeglusin decreased BCL2 expression levels in HL-60 and KG-1 cells. Reference: Front Oncol. 2022 Jun 29;12:864430. https://pubmed.ncbi.nlm.nih.gov/35847946/
In vivo activity: Inhibition of β-hydroxy-β-methylglutaryl (HMG)-CoA synthase (HMGCS2) with hymeglusin lowered ischaemic β-OHB accumulation by 40%, despite increased flux through succinyl-CoA-3-oxaloacid CoA transferase (SCOT), resulting in greater contractile recovery. Hymeglusin also protected cardiac mitochondrial respiratory capacity during ischaemia/reperfusion in rats. Reference: Elife. 2021 Sep 7;10:e71270. https://pubmed.ncbi.nlm.nih.gov/34491199/

Preparing Stock Solutions

The following data is based on the product molecular weight 324.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Zhou C, Wang Z, Yang S, Li H, Zhao L. Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia. Front Oncol. 2022 Jun 29;12:864430. doi: 10.3389/fonc.2022.864430. PMID: 35847946; PMCID: PMC9277771. 2. Skaff DA, Ramyar KX, McWhorter WJ, Barta ML, Geisbrecht BV, Miziorko HM. Biochemical and structural basis for inhibition of Enterococcus faecalis hydroxymethylglutaryl-CoA synthase, mvaS, by hymeglusin. Biochemistry. 2012 Jun 12;51(23):4713-22. doi: 10.1021/bi300037k. Epub 2012 May 25. PMID: 22510038; PMCID: PMC3431454. 3. Lindsay RT, Dieckmann S, Krzyzanska D, Manetta-Jones D, West JA, Castro C, Griffin JL, Murray AJ. β-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery. Elife. 2021 Sep 7;10:e71270. doi: 10.7554/eLife.71270. PMID: 34491199; PMCID: PMC8423437. 4. Tomoda H, Ohbayashi N, Morikawa Y, Kumagai H, Omura S. Binding site for fungal beta-lactone hymeglusin on cytosolic 3-hydroxy-3-methylglutaryl coenzyme A synthase. Biochim Biophys Acta. 2004 Feb 27;1636(1):22-8. doi: 10.1016/j.bbalip.2003.11.005. PMID: 14984735.
In vitro protocol: 1. Zhou C, Wang Z, Yang S, Li H, Zhao L. Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia. Front Oncol. 2022 Jun 29;12:864430. doi: 10.3389/fonc.2022.864430. PMID: 35847946; PMCID: PMC9277771. 2. Skaff DA, Ramyar KX, McWhorter WJ, Barta ML, Geisbrecht BV, Miziorko HM. Biochemical and structural basis for inhibition of Enterococcus faecalis hydroxymethylglutaryl-CoA synthase, mvaS, by hymeglusin. Biochemistry. 2012 Jun 12;51(23):4713-22. doi: 10.1021/bi300037k. Epub 2012 May 25. PMID: 22510038; PMCID: PMC3431454.
In vivo protocol: 1. Lindsay RT, Dieckmann S, Krzyzanska D, Manetta-Jones D, West JA, Castro C, Griffin JL, Murray AJ. β-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery. Elife. 2021 Sep 7;10:e71270. doi: 10.7554/eLife.71270. PMID: 34491199; PMCID: PMC8423437. 2. Tomoda H, Ohbayashi N, Morikawa Y, Kumagai H, Omura S. Binding site for fungal beta-lactone hymeglusin on cytosolic 3-hydroxy-3-methylglutaryl coenzyme A synthase. Biochim Biophys Acta. 2004 Feb 27;1636(1):22-8. doi: 10.1016/j.bbalip.2003.11.005. PMID: 14984735.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Skaff DA, Ramyar KX, McWhorter WJ, Barta ML, Geisbrecht BV, Miziorko HM. Biochemical and structural basis for inhibition of Enterococcus faecalis hydroxymethylglutaryl-CoA synthase, mvaS, by hymeglusin. Biochemistry. 2012 Jun 12;51(23):4713-22. doi: 10.1021/bi300037k. PubMed PMID: 22510038; PubMed Central PMCID: PMC3431454.

2: Carazo A, Alejandre MJ, Louktibi A, Linares A. The reversal of the inhibition on lipids synthesis by L-659,699 in arterial smooth muscle cells cultures. Mol Cell Biochem. 2001 May;221(1-2):25-31. PubMed PMID: 11506182.

3: Ginger ML, Chance ML, Sadler IH, Goad LJ. The biosynthetic incorporation of the intact leucine skeleton into sterol by the trypanosomatid Leishmania mexicana. J Biol Chem. 2001 Apr 13;276(15):11674-82. PubMed PMID: 11148203.

4: Rokosz LL, Boulton DA, Butkiewicz EA, Sanyal G, Cueto MA, Lachance PA, Hermes JD. Human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase: expression, purification, and characterization of recombinant wild-type and Cys129 mutant enzymes. Arch Biochem Biophys. 1994 Jul;312(1):1-13. PubMed PMID: 7913309.

5: Giron MD, Havel CM, Watson JA. Isopentenoid synthesis in eukaryotic cells. An initiating role for post-translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Arch Biochem Biophys. 1993 Apr;302(1):265-71. PubMed PMID: 8097083.

6: Greenspan MD, Bull HG, Yudkovitz JB, Hanf DP, Alberts AW. Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by beta-lactone inhibitors and binding of these inhibitors to the enzyme. Biochem J. 1993 Feb 1;289 ( Pt 3):889-95. PubMed PMID: 8094614; PubMed Central PMCID: PMC1132259.

7: Greenspan MD, Yudkovitz JB, Lo CY, Chen JS, Alberts AW, Hunt VM, Chang MN, Yang SS, Thompson KL, Chiang YC, et al. Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7488-92. PubMed PMID: 2890166; PubMed Central PMCID: PMC299321.